Cytokine Induction of Fas Gene Expression in Insulin-Producing Cells Requires the Transcription Factors NF-κB and C/EBP

Diabetes

Volumn 50, Issue 8, 2001, Pages 1741-1748

  Darville, Martine I ^a   Eizirik, Décio L ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CYTOKINE; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; INSULINOMA; METABOLISM; MOUSE; PANCREAS TUMOR; PROMOTER REGION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; ANTIGENS, CD95; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULINOMA; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-1; MICE; NF-KAPPA B; PANCREATIC NEOPLASMS; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; RATS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035432603     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.8.1741     Document Type: Article

References (55)

1. Kurrer MO, Pakala SV, Hanson HL, Katz JD: β cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A 94:213-218, 1997
2. O'Brien BA, Harmon BV, Cameron DP, Allan DJ: Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 46:750-757, 1997
3. Mauricio D, Mandrup-Poulsen T: Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes 47:1357-1363, 1998
4. Rothe H, Faust A, Schade U, Kleeman R, Bosse G, Hibino T, Martin S, Kolb H: Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-γ, but not interleukin-4. Diabetologia 37:1154-1158, 1991
5. Rabinovitch A, Suarez-Pinzon WL, Sorenson O, Bleackley RC: Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS-expressing cells and relationships to rytokines expressed in the islets. Endocrinology 137:2093-2099, 1996
6. Eizirik DL, Pavlovic D: Is there a role for nitric oxide in β-cell dysfunction and damage in IDDM? Diabetes Metab Rev 13:293-308, 1997
7. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DL: Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138:2610-2614, 1997
8. Hoorens A: Distinction Between Necrosis and Apoptosis of Pancreatic Beta Cells. PhD thesis. Brussels, Belgium, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, 1999
9. / ). Diabetes 49:1116-1122, 2000
10. Mandnip-Poulsen T: The role of interleukin-1 in the pathogenesis of insulin-dependent diabetes mellitus. Diabetologia 39:1005-1029, 1996
11. Rabinovitch A: An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14:129-151, 1998
12. Eizirik DL, Darville MI: β-cell apoptosis and defense mechanisms: lessons from type 1 diabetes mellitus. Diabetes 50 (Suppl. 1):S64-S69, 2001
13. Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C, Nonaka K: Mouse islet cell lysis mediated by IL-1-induced Fas. Diabetologia 39:1306-1312. 1996
14. Stassi G, Maria RD. Trucco G, Rudert W, Testi R, Galluzo A, Giordano C, Trucco M: Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 186:1193-1200, 1997
15. Zumsteg U, Frigerio S, Holländer GA: Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine β-cell damage. Diabetes 49:39-47, 2000
16. + T lymphocytes. J Clin Invest 105:459-468, 2000
17. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456, 1995
18. Nagata S: Apoptosis by death factor. Cell 88:355-365, 1997
19. Suarez-Pinzon W, Sorensen O, Bleackley JF, Elliot JF, Rajotte RV, Rabinovitch A: β-cell destruction in NOD mice correlates with Fas (CD95) expression on β-cells and proinflammatory cytokine expression in islets. Diabetes 48:21-28, 1999
20. Allison J, Strasser A: Mechanisms of β cell death in diabetes: a minor role for CD95. Proc Natl Acad Sci U S A 95:13818-13822, 1998
21. Kim S, Kim KA, Hwang DY, Lee TH, Kayagaki N, Yagita H, Lee MS: Inhibition of autoimmune diabetes by Fas ligancl: the paradox is solved. J Immunol 164:2931-2936, 2000
22. Su X, Hu Q, Kristan JM, Costa C, Shen Y, Gero D, Maus LA, Wang Y: Significant role for Fas in the pathogenesis of autoimmune diabetes. J Immunol 164: 2523-2532, 2000
23. Suarez-Pinzon WL, Power RF, Rabinovitch A: Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice. Diabetologia 43:1149-1156, 2000
24. Thomas HE, Darwiche R, Corbett JA, Kay TW: Evidence that beta cell death in the nonobese diabetic mouse is Fas independent. J Immunol 163:1562-1569, 1999
25. Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, Iwahashi H, Nakajima H, Namba M, Nagata S, Hanafusa T, Matsuzawa Y: Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset type I diabetes mellitus. Diabetologia 42:1332-1340, 1999
26. Xu X, Fu XY, Plate J, Chong ASF: IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res 38:2832-2837, 1998
27. Ouaaz F, Li M, Beg AA: A critical role for the RelA subunit of nuclear factor κB in regulation of multiple immune-response genes and in Fas-induced cell death. J Exp Med 1811:999-1004, 1999
28. Kimura K, Asami K, Yamamoto M: Structure of the promoter for the rat Fas antigen gene, Biochim Biophys Acta 1352:238-242, 1997
29. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: Current Protocols in Molecular Biology. New York, Wiley & Sons, 1994, p. 2.2.1-2.2.3
30. Coolidge CJ, Patton JG: Run-around PCR: a novel way to create duplications using polymerase chain reaction. BioTechniques 18:763-764, 1995
31. Liu H, Sidiropoulos P, Guobin S, Pagliari LJ, Birrer MJ, Stein B, Anrather J, Pope RM: TNF-α gene expression in macrophages: regulation by NF-κB is independent of c-jun or C/EBPβ. J Immunol 164:4277-4285, 2000
32. Pipeleers DG, in't Veld PA, Van De Winckel M, Macs E, Schuit FC, Gepts W: A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806-816, 1985
33. Ling Z, Hannaert JC, Pipeleers D: Effect of nutrients, hormones and serum on survival of rat islet β cells in culture. Diabetologia 37:15-20, 1994
34. Schuit FC, Pipeleers DG: Regulation of adenosine 3′, 5′-monophosphate levels in the pancreatic β cell. Endocrinology 117:834-840, 1985
35. Darville MI, Eizirik DL: Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41:1101-1108, 1998
36. Bedoya FJ, Flodström M, Eizirik DL: Pyrrolidine dithiocarbamate prevents IL-1-induced nitric oxide synthase mRNA. but not superoxide dismutase mRNA, in insulin-producing cells. Biochem Biophys Res Commun 210: 816-822, 1995
37. Flodström M, Eizirik DL: Interferon-γ-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production. Endocrinology 138:2747-2753, 1997
38. Darville MI, Ho Y-S, Eizirik DL: NF-κB is required for cytokine-induced manganese superoxide dismutase expression in insulin-producing cells. Endocrinology 141:153-162, 2000
39. Schreiber E, Matthias P, Müller MM, Schaffner W: Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucl Acids Res 17:6419, 1989
40. Stein B, Baldwin AS: Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-κB. Mol Cell Biol 13:7191-7198, 1993
41. Catron KM, Brickwood JR, Shang C, Li Y, Shannon MF, Parks TP: Cooperative binding and synergistic activation by RelA and C/EBPβ on the intercellular adhesion molecule-1 promoter. Cell Growth Differ 9:949-959, 1998
42. Stein B, Cogswell PC, Baldwin AS: Functional and physical associations between NF-κB and C/EBP family members: a Rel domain-bZIP interaction. Mol Cell Biol 13:3964-3974, 1993
43. Ray A, Hannink M, Ray BK: Concerted participation of NF-κB and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver. J Biol Chem 270:7365-7374, 1995
44. Plevy SE, Gemberling JHM, Hsu S, Dorner AJ, Smale ST: Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol Cell Biol 17:4572-4588, 1997
45. Baldwin AS: The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14:649-686, 1996
46. Ballard DW, Dixon EP, Peffer NJ, Bogerd H, Doerre S, Stein B, Greene WC: The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc Natl Acad Sci U S A 89:1875-1879, 1992
47. Stylianou E, Nie M, Ueda A, Zhao L: c-Rel and p65 trans-activate the monocyte chemoattractant protein-1 gene in interleukin-1 stimulated mesangial cells. Kidney Int 56:873-882, 1999
48. Ping D, Boekhoudt GH, Rogers EM, Boss JM: Nuclear factor-κB p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene. J Immunol 162:727-734, 1999
49. Lee SJ, Hou J, Benveniste EN: Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-κB and C/EBP isoforms. J Neuroimmunol 92:196-207, 1998
50. Ruocco MR, Chen X, Ambrosino C, Dragonetti E, Liu W, Mallardo M, De Falco G, Palmieri C. Franzoso G, Quinto I, Venuta S, Scala G: Regulation of HIV-1 long terminal repeats by interaction of C/EBP (NF-IL6) and NF-κB/ Rel transcription factors. J Biol Chem 271:22479-22486, 1996
51. Trautwein C, Caelles C, van der Geer P, Hunter T, Karin M, Chojkier M: Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 364:544-547, 1993
52. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T: CREB-binding protein/p300 are transcriptional coactivaters of p65. Proc Natl Acad Sci U S A 94:2927-2932, 1997
53. Vanden Berghe W, De Bosscher K, Boone E, Plaisance S, Haegeman G: The nuclear factor-κB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem 274:32091-32098, 1999
54. John S, Reeves RB, Lin JX, Child R, Leiden JM, Thompson CB, Leonard WJ: Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins. Mol Cell Biol 15:1786-1796, 1995
55. Yie J, Merika M, Munshi N, Chen G, Thanos D: The role of HMG I(Y) in the assembly and function of the IFN-β enhanceosome. EMBO J 18:3074-3089, 1999